Provention Bio

+$0.08 (+1.34%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Provention Bio and other ETFs, options, and stocks.

About PRVB

Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D); PRV-015 for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 for Crohn’s disease; PRV-3279 for the treatment of lupus; and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset.

CEO

Ashleigh W. Palmer

Employees

—

Headquarters

Red Bank, New Jersey

Founded

2016

PRVB Key Statistics

Market Cap

490.46M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.04M

High Today

$6.10

Low Today

$5.72

Open Price

$5.93

Volume

641.85K

52 Week High

$20.05

52 Week Low

$5.59

Analyst Ratings

71%

of 7 ratings

Buy

71.4%

Hold

28.6%

Sell

PRVB Earnings

-$0.58

-$0.30

-$0.02

$0.26

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 5, Pre-Market